Literature DB >> 29686566

Mixed phenotypic acute leukemia.

John R Krause1, Sarah Findeis1.   

Abstract

Mixed phenotypic acute leukemias (MPALs) are a heterogeneous group of rare leukemias constituting about 1% to 5% of all leukemias. MPAL is defined as an acute leukemia that demonstrates expression of a combination of antigens of different lineages so that it is not possible to assign a single lineage to that leukemia. These leukemias have been characterized by relative therapeutic resistance. We present a case of a woman with an acute MPAL diagnosed as a B/myeloid leukemia.

Entities:  

Keywords:  B/myeloid leukemia; mixed lineage leukemia; mixed phenotypic acute leukemias

Year:  2018        PMID: 29686566      PMCID: PMC5903509          DOI: 10.1080/08998280.2017.1400317

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  How I treat mixed-phenotype acute leukemia.

Authors:  Ofir Wolach; Richard M Stone
Journal:  Blood       Date:  2015-01-20       Impact factor: 22.113

2.  Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

Authors:  Estella Matutes; Winfried F Pickl; Mars Van't Veer; Ricardo Morilla; John Swansbury; Herbert Strobl; Andishe Attarbaschi; Georg Hopfinger; Sue Ashley; Marie Christine Bene; Anna Porwit; Alberto Orfao; Petr Lemez; Richard Schabath; Wolf-Dieter Ludwig
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

3.  Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.

Authors:  Olga K Weinberg; Mahesh Seetharam; Li Ren; Ash Alizadeh; Daniel A Arber
Journal:  Am J Clin Pathol       Date:  2014-12       Impact factor: 2.493

Review 4.  Mixed-phenotype acute leukemia: historical overview and a new definition.

Authors:  O K Weinberg; D A Arber
Journal:  Leukemia       Date:  2010-09-16       Impact factor: 11.528

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

7.  A Study on the Expression of BCR-ABL Transcript in Mixed Phenotype Acute Leukemia (MPAL) Cases Using the Reverse Transcriptase Polymerase Reaction Assay (RT-PCR) and its Correlation with Hematological Remission Status Post Initial Induction Therapy.

Authors:  Prateek Bhatia; Jogeshwar Binota; Neelam Varma; Deepak Bansal; Amita Trehan; Ram Kumar Marwaha; Pankaj Malhotra; Subhash Varma
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-08       Impact factor: 2.576

8.  Mixed-phenotype acute leukemia (MPAL) and beyond.

Authors:  Hee-Je Kim
Journal:  Blood Res       Date:  2016-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.